340 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Why Allergan (AGN) Could Beat Earnings Estimates Again http://www.zacks.com/stock/news/345813/why-allergan-agn-could-beat-earnings-estimates-again?cid=CS-ZC-FT-345813 Jan 04, 2019 - Allergan (AGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why FedEx, Allergan, and FTS International Slumped Today https://www.fool.com/investing/2018/12/19/why-fedex-allergan-and-fts-international-slumped-t.aspx?source=iedfolrf0000001 Dec 19, 2018 - Find out which stocks fell on an important day for monetary policy.
Bausch (BHC) Bids for Assets of Synergy Pharmaceuticals http://www.zacks.com/stock/news/342745/bausch-bhc-bids-for-assets-of-synergy-pharmaceuticals?cid=CS-ZC-FT-342745 Dec 13, 2018 - Bausch (BHC) bids to acquire certain assets of Synergy Pharma for $200 million.
Allergan plc (AGN) CEO Brenton Saunders Presents at Citi Global Healthcare Conference (Transcript) https://seekingalpha.com/article/4226833-allergan-plc-agn-ceo-brenton-saunders-presents-citi-global-healthcare-conference-transcript?source=feed_sector_healthcare Dec 06, 2018 - Allergan plc (NYSE:AGN) Citi Global Healthcare Conference (Transcript) December 6, 2018, 11:00 AM ET Executives Brenton Saunders - Chairman, President and Chief Executive Officer Analysts Liav Abraham
Okta (OKTA) Q3 Earnings and Revenues Surpass Estimates http://www.zacks.com/stock/news/341624/okta-okta-q3-earnings-and-revenues-surpass-estimates?cid=CS-ZC-FT-341624 Dec 06, 2018 - Okta's (OKTA) third-quarter fiscal 2019 results benefit from increasing adoption of the company's Identity solutions.
3 Stocks That Are Absurdly Cheap Right Now https://www.fool.com/investing/2018/11/26/3-stocks-that-are-absurdly-cheap-right-now.aspx?source=iedfolrf0000001 Nov 26, 2018 - If you got trampled during a Black Friday sale and had to return home without wares, these three bargain stocks will make you feel better. Waiting in line not required.
FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz http://www.zacks.com/stock/news/338827/fda-accepts-allergans-agn-snda-for-anti-infective-avycaz?cid=CS-ZC-FT-338827 Nov 21, 2018 - The FDA accepts Allergan's (AGN) sNDA for the label expansion of its antibacterial medicine, Avycaz, to treat cUTI and cIAI in pediatric patients.
Is Allergan (AGN) a Great Stock for Value Investors? http://www.zacks.com/stock/news/338321/is-allergan-agn-a-great-stock-for-value-investors?cid=CS-ZC-FT-338321 Nov 19, 2018 - Let's see if Allergan (AGN) stock is a good choice for value-oriented investors right now from multiple angles.
Is Agnes Gund the Last Good Rich Person? https://www.nytimes.com/2018/11/03/style/agnes-gund-philanthropy.html?partner=rss&emc=rss Nov 05, 2018 - Ms. Gund is a wealthy white woman who spent a lifetime fighting for racial justice. At 80, she’s the homecoming queen of the philanthropy world. She’s also running out of cash.
Drug Stocks to Post Earnings on Nov 5: MYL, NBIX, RARE, TARO http://www.zacks.com/stock/news/334797/drug-stocks-to-post-earnings-on-nov-5-myl-nbix-rare-taro?cid=CS-ZC-FT-334797 Nov 02, 2018 - We see how things are shaping up for the four pharma/biotech companies, which are scheduled to release second-quarter earnings on Nov 5.

Pages: 1234567891011...34

<<<Page 6>